Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Advanced Medical Isotope Corporation (RDGL) had Return on Equity of 7.08% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.00M |
|
$-0.51M |
|
$0.01M |
|
$-0.01M |
|
$0.53M |
|
$-0.53M |
|
$0.02M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.53M |
|
$-0.53M |
|
454.31M |
|
454.31M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$2.30M |
|
-- |
|
-- |
|
$2.30M |
|
$0.11M |
|
-- |
|
-- |
|
$0.11M |
|
$-7.17M |
|
$2.18M |
|
$2.18M |
|
454.66M |
|
| Cash Flow Statement Financials | |
$-1.52M |
|
-- |
|
$1.51M |
|
$2.21M |
|
$2.20M |
|
$-0.01M |
|
$0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.52M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.23 |
|
0.40 |
|
225.07 |
|
|
Return on Equity |
7.08% |
-23.24% |
|
-22.10% |
|
-23.24% |
|
$0.00 |
|
$-0.00 |
|
$-0.00 |
|